Growth Metrics

Bio-Techne (TECH) Other Non-Current Liabilities (2016 - 2025)

Bio-Techne has reported Other Non-Current Liabilities over the past 12 years, most recently at $23.1 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $23.1 million for Q4 2025, up 103.56% from a year ago — trailing twelve months through Dec 2025 was $23.1 million (up 103.56% YoY), and the annual figure for FY2025 was $27.1 million, up 105.84%.
  • Other Non-Current Liabilities for Q4 2025 was $23.1 million at Bio-Techne, down from $23.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for TECH hit a ceiling of $27.1 million in Q2 2025 and a floor of $4.8 million in Q1 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $11.9 million (2022), compared with a mean of $14.3 million.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 74.69% in 2021 and later surged 128.6% in 2023.
  • Bio-Techne's Other Non-Current Liabilities stood at $7.0 million in 2021, then soared by 61.94% to $11.3 million in 2022, then soared by 53.15% to $17.4 million in 2023, then plummeted by 34.7% to $11.3 million in 2024, then soared by 103.56% to $23.1 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $23.1 million (Q4 2025), $23.8 million (Q3 2025), and $27.1 million (Q2 2025) per Business Quant data.